Filtyp
CREATE Health, inaugurated in 2006 with a focus on precision medicine, is a strategic centre for translational research focusing on the early diagnosis and prognosis of cancer, as well as the development of novel treatment strategies. Our vision: To accelerate translation of breakthrough therapies and diagnostics into clinical practice, improving outcomes for today´s cancer patients while building
https://www.createhealth.lth.se/about - 2026-04-17
Our research accompanies the entire patient journey, from initial diagnosis through treatment and companion diagnostics to quality-of-life enhancement during and after cancer. We deliver translational solutions that start from specific clinical needs identified by our clinical partners, leveraging novel technological approaches to accelerate implementation into the clinic with dramatically reduced
https://www.createhealth.lth.se/research - 2026-04-17
Lund University research projects Currently at Lund Univeristy, ten research projects are driven by ten Principle Investigators from the Faculty of Engineering (LTH) and the Faculty of Medicine. The common goal of all of them is to deepen knowledge and fast forward innovations in cancer diagnostics and treatment. Molecular characterisation of breast cancer: biomarkers of risk, prognosis and treatm
https://www.createhealth.lth.se/research/research-projects - 2026-04-17
Please wait...
https://www.createhealth.lth.se/contact/principal-investigators - 2026-04-17
In 2025, CREATE Health Translational Cancer Center received a donation from the Mrs Berta Kamprad’s Cancer Foundation of 420 million SEK. This is the single largest donation to Lund University, since its founding in 1666. The funds are distributed over a five-year period and dedicated to translational cancer research within the L2CancerBridge programme.Other previous and current funding for the CR
https://www.createhealth.lth.se/about/funding - 2026-04-17
L2CancerBridge is a groundbreaking collaborative cancer research programme that bridges two of Europe's leading research institutions: CREATE Health at Lund University, Sweden, and the Swiss Cancer Centre at EPFL in Lausanne, Switzerland. The L2CancerBridge programme exemplifies how international partnerships can accelerate cancer research breakthroughs. By combining the expertise and resources of
https://www.createhealth.lth.se/research/l2cancerbridge-programme-collaborative-excellence - 2026-04-17
Please wait...
https://www.createhealth.lth.se/contact/antibody-unit - 2026-04-17
Antibody Initiative Advances in antibody engineering have revolutionised cancer therapy, and biological drugs now constitute a cornerstone of frontline treatment across most cancer subtypes. We drive continued innovation and clinical success by continuously enhancing local capabilities in Lund to develop tailored molecules for targeted cancer treatment- specific antigens, immune checkpoints, or as
https://www.createhealth.lth.se/research/technologies - 2026-04-17
November 24, 2025. COMMONS Early Career DayWe are thrilled to follow up on our previous announcement for COMMONS Early Career Day! This is a wonderful opportunity to connect with peers from Sweden, Denmark, and beyond in an informal and friendly setting.Date: 24th November 2025Location: The Loop, Rydbergs torg 4, LundWhy attend?• Present and discuss your ongoing projects• Talk openly about topics
https://www.commons-center.lu.se/commons-early-career-day - 2026-04-17
COMMONS seeks to bridge disciplines and audiences by engaging the public and connecting the natural sciences with the social sciences and humanities through its Academic Forum. Academic Forum activities include essay writing on natural science topics, interdisciplinary panel discussions, and seminar-style conversations. Julia Ravanis is the Academic forum at Folkteatern, GothenburgCOMMONS co‑organ
https://www.commons-center.lu.se/academic-forum - 2026-04-17
26 May 2026 17:30 to 20:00 | Seminar COMMONS coorganizes public lectures and discussions evenings at Folkteatern in Gothenburg2026-05-26 TransformationsAre we standing on the verge of a tipping point that will transform our world? Can the phase transitions of matter help us understand more about climate change, or political change?Invited guests to be announced soon.Co-arranged with the cultural j
https://www.commons-center.lu.se/calendar/academic-forum-transformations - 2026-04-17
Faunus Faunus is a free, object oriented library for classical molecular simulations written in C++/Python. Besides handling macromolecular solutions in various ensembles such as NVT, μVT, NPT, Faunus also covers more excotic topics such as proton fluctuations, arbitrary parallel tempering and hyperspherical geometry.More information on the Faunus website Molcas MOLCAS is a quantum chemistry softw
https://www.compchem.lu.se/infrastructure/software - 2026-04-17
In 2021 Infrastructure Call at Lund University, we were gratefully approved funding from LU Central, the Science Faculty, and the Faculty of Engineering for purchasing a Solution X-ray Scattering Instrument for Life Science and Soft Matter, short-name the BioSAXS. Our vision is to promote the usage of X-ray and neutron scattering techniques and provide the researchers at LU with a facility where i
https://www.compchem.lu.se/infrastructure/biosaxs-instrument - 2026-04-17
Current vacanciesCurrent job vacancies at the Division of Computational Chemistry (Varbi)To apply for a vacant position, you need an account in Lund University’s recruitment system, Varbi.How to apply for a position (Lund University’s website) Industrial PhD student in Machine Learning and Drug Design in Molecular AI
https://www.compchem.lu.se/about/job-vacancies - 2026-04-17
Vem kan vara med i DORIS-studien?Vad innebär deltagande i studien?Hur kommer jag med i studien?Vem kan vara med i DORIS-studien?Barn som ingår i neonatalvårdens nationella uppföljningsprogram och som bor i Södra Sveriges sjukvårdsregion, ska erbjudas deltagande i studien.Här ingår: Barn som är föds extremt för tidigt, dvs. innan graviditetsvecka 28Barn med en extremt låg födelsevikt (<3SD)Barn som
https://www.doris.lu.se/om-doris - 2026-04-17
Deltagande i DORIS-studien innebär att vi följer ditt barns utveckling med nogsam informationsinhämtning under de första två åren. Du får fylla i skattningsformulär när ditt barn är 6, 12 och 18 månaders ålder. Formulären skickas till din hemadress med post och ifyllda formulär ska returneras till oss i ett svarskuvert. Vid 2 år och 5,5 års ålder kallas barnet för sedvanligt besök på Neonatalmott
https://www.doris.lu.se/om-doris/vad-innebar-deltagande-i-studien - 2026-04-17
Om ditt barn ingår i en av de neonatala riskgrupper som studien följer ska Neonatalmottagningen på ert hemsjukhus informera dig om studien. Fråga gärna din Neonatalmottagning om du är osäker på om ditt barn uppfyller kriterier för att ingå i DORIS-studien! Du kan också ta kontakt med DORIS-studiens ansvariga via de kontaktuppgifter du hittar här på hemsidan, under fliken Kontakt.
https://www.doris.lu.se/om-doris/hur-kommer-jag-med-i-studien - 2026-04-17
0-18 månader 2 år 5 år 10 år 0-18 månaderDeltagande i studien innebär att en av vårdnadshavarna kommer att få fylla i ett antal frågeformulär, när barnet är 6, 12 respektive 18 månader gammalt.Formulären undersöker barnets utveckling, beteende och mående, samt förälderns eget mående och upplevelse av föräldraskapet till barnet. Det kan ta 1-2 timmar/tillfälle att svara på frågeformulären. Formulär
https://www.doris.lu.se/information-till-deltagare - 2026-04-17
ForskningsbidragDORIS-studien har mottagit generösa forskningsbidrag från:Drottning Silvias JubileumsfondCrafoordska StiftelsenSveriges Neuropsykologers RiksförbundLilla Barnets FondSkånes UniversitetssjukhusVi är tacksamma för att dessa aktörer valt att stödja studien! KlinikerDORIS-studien inkluderar barn som är inskrivna vid Neonatalmottagningarna i Lund, Malmö, Helsingborg, Kristianstad, Karls
https://www.doris.lu.se/samarbeten - 2026-04-17
När får vi formulären?Mitt barn föddes för tidigt. När ska jag fylla i formulären?Jag förstår inte instruktionerna i formulären. Hur gör jag?Formulär har kommit bort. Hur gör jag?Måste alla formulär fyllas i vid samma tidpunkt?Vissa av frågorna i formulären verkar vara för äldre barn än mitt?Hur får jag ta del av resultat i DORIS-studien? När får vi formulären?Vanligtvis skickas formulär ut med po
https://www.doris.lu.se/faq - 2026-04-17
